Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Australian Stem Cell Therapy Wins Global Recognition
Research & Development Australian Stem Cell Therapy Wins Global Recognition

In a remarkable breakthrough for stem cell research, a team of Australian scientists from Magellan Stem Cells has been celebrated globally for their pioneering work in osteoarthritis clinical research. These researchers have received the esteemed Research Publication of the Year Award from a

Lean Strategies for Pharma: Enhancing Compliance and Efficiency
Biotech & Bioprocessing Lean Strategies for Pharma: Enhancing Compliance and Efficiency

In the pharmaceutical industry, adherence to Lean manufacturing principles is often hindered by stringent regulatory environments such as Good Manufacturing Practices (GMP). Lean methodologies aim to minimize waste and boost efficiency. However, integrating these principles without compromising

How Will Imaging Associates' Expansion Impact Radiology?
Tech & Innovation How Will Imaging Associates' Expansion Impact Radiology?

Imaging Associates, a prominent radiology provider in Victoria, Australia, has embarked on a transformative expansion that promises to reshape the landscape of radiology services in the region. This strategic growth, underscored by the acquisition of the reputable DiagnostiCare practice,

Are Nigerian Hospitals Ready for Power Outage Emergencies?
Management & Regulatory Are Nigerian Hospitals Ready for Power Outage Emergencies?

In recent years, the healthcare system in Nigeria has faced significant challenges, one of which is the unreliable power infrastructure that plagues many government-run hospitals. This issue is not just an inconvenience but a potential threat to life, as critical medical operations depend on a

DuPont Launches Ultra-Low Temp Tubing for Biopharma Sector
Biotech & Bioprocessing DuPont Launches Ultra-Low Temp Tubing for Biopharma Sector

In recent developments within the biopharmaceutical sector, DuPont has taken a significant step forward by unveiling its latest offering. The introduction of Liveo Pharma TPE Ultra-Low Temp Tubing marks an innovative expansion of DuPont's product line, specifically targeted at the stringent

De-Risking Biologics Through Early Assessment Tools
Editorial De-Risking Biologics Through Early Assessment Tools

Predicting how a biotherapeutic will behave in humans is a critical step in drug design —but it's far from straightforward. While nonclinical models can help foresee certain negative effects, they often fall short when it comes to immunotoxicity and other immune-related reactions. With the g

AI Revolutionizes Healthcare with Smart Assistants and Better Care
Tech & Innovation AI Revolutionizes Healthcare with Smart Assistants and Better Care

Artificial intelligence (AI) is increasingly becoming embedded in the fabric of modern medicine, creating significant changes in how healthcare professionals deliver patient care. The adoption of AI technologies has ushered in a new era where AI acts akin to a "super smart assistant,

How Do Clinicians Overcome Telemedicine Prescribing Challenges?
Tech & Innovation How Do Clinicians Overcome Telemedicine Prescribing Challenges?

Telemedicine has revolutionized healthcare delivery, enabling clinicians to prescribe medications remotely. This paradigm shift, while enhancing patient access to care, also introduces distinct challenges that providers must navigate to ensure effective treatment. Successful long-term telemedicine

Can Stem Cell Therapy Transform Parkinson's Disease Treatment?
Research & Development Can Stem Cell Therapy Transform Parkinson's Disease Treatment?

Parkinson's disease, a progressive and degenerative brain condition, affects more than 1 percent of individuals over the age of 60 worldwide, leading to symptoms such as slow movements, muscle tremors, stiffness, and difficulty walking. Traditional treatments focus primarily on managing

Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?
Management & Regulatory Why Are Hedge Funds Investing Big in AI and MedTech Healthcare?

The fourth quarter of 2024 witnessed a significant surge in hedge fund investments focused on the healthcare sector, particularly emphasizing advancements in artificial intelligence (AI), biotechnology, and medical technology (MedTech). This pivotal period showcased growing confidence among

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later